These include thyroid, prostate, breast, bladder and lung cancers, as well as interstitial lung diseases. Nasdaq: VCYT. $19.85. Apr 22, 2024 ...
Find the latest SEC Filings data for Veracyte, Inc. Common Stock (VCYT) ... Investor Relations Intelligence. Featured ... Common Stock (VCYT). Nasdaq Listed · Nasdaq ...
People also ask
Is veracyte a public company?
What does veracyte do?
What are the values of veracyte?
Who is the founder of veracyte?
VCYT Veracyte, Inc. Earnings Call Transcripts - Seeking Alpha
seekingalpha.com › symbol › transcripts
A high-level overview of Veracyte, Inc. (VCYT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment ...
Missing: relations | Show results with:relations
Veracyte, Inc. Common Stock (VCYT) Earnings Report Date | Nasdaq
www.nasdaq.com › ... › Stocks › VCYT
Find annual and quearterly earnings data for Veracyte, Inc. Common Stock (VCYT) including earnings per share, earnings forecasts at Nasdaq.com.
Find the latest Veracyte, Inc. (VCYT) stock quote, history, news and other vital information to help you with your stock trading and investing.
Rating
(3,975)
Veracyte (VCYT) will release its next earnings report on Apr 29, 2024. In the last quarter Veracyte reported -$0.1 EPS in relation to -$0.39 expected by the ...
Feb 23, 2024 · In this article: VCYT ... Veracyte, Inc. misses on earnings expectations. Reported EPS is $-0.39 EPS, expectations were $-0.07. Veracyte, Inc. isn ...